Show simple item record

dc.contributor.authorBelay, Yilkal Tariku
dc.date.accessioned2022-04-19T13:11:59Z
dc.date.available2022-04-19T13:11:59Z
dc.date.issued2019
dc.identifier.citationBelay, Y. T. (2019). Parameters for grading the toxic severity of test chemicals : a review article in the advancement of unknown drugs into the clinic. Advances in Nanomedicine and Nanotechnology Research, 1(2): 43-52.en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12281/11737
dc.descriptionThis is an open access article that can be accessed directly from the publisher at www.scitcentral.com in the "Advances in Nanomedicine and Nanotechnology Research" Journal, December 2019 Issue, 1(2): 43-52.en_US
dc.description.abstractGrading of toxic severity of a test chemical is a routine procedure in experimental toxicology to support regulatory policy in categorisation and harmful labeling decisions. Harmful labeling decision is usually made on the basis of lethal dose administered to study animal. However, the toxic property of a chemical compound is diverse in which the undesired biological mechanism manifested on treated study animal may not cause death within the period of the experiment. The length of time at which undesired biological effects manifest on study animal depend on the amount of administered dose. The adverse effect of higher dose usually manifests within a shorter period of time than the lower doses. The scientific basis of drug action is the interaction of a drug with its receptor or biological target by which undesired biological changes manifested at the cellular, organs or organismal level depending on the amount of administered test chemical. Drug metabolism is an important biological process to be considered in the study of pharmacological activity of test chemical compounds. It is one of the primary mechanisms by which a chemical compound is inactivated or activated depending on the metabolic enzyme systems involved in biotransformation. Biotransformation of test chemical perhaps leads to the production of reactive metabolites that could be more toxic, mutagenic or carcinogenic than parent chemical compound which could elicit different biological responses such as loss of appetite and suppressed immune response among others. The metabolic and immune systems are highly interrelated in which the proper function of one is highly dependent on the other. Metabolic dysfunction for instance leads to deteriorated immune system which can be evaluated by clinical parameters such as differential blood cell counts (i.e., T-lymphocytes and B-lymphocytes) and immunoglobulin concentration in blood serum. In conclusion, Grading of toxic severity of test chemicals should take into account not only the estimate of hazards on the basis of lethal dose administered into the biological system but also the different biological responses (immunological and physiological) and the length of time at which biological responses manifested in the course of metabolism. Quantitative analysis of undesired biological responses as toxic severity and toxic reaction rate is paramount for grading the toxic severity of test chemical compounds on study subject which allow better identification of real risks to public health safety.en_US
dc.language.isoenen_US
dc.publisherAdvances in Nanomedicine and Nanotechnology Researchen_US
dc.subjectGradingen_US
dc.subjectToxic severityen_US
dc.subjectTest chemicalen_US
dc.subjectRegulatory policyen_US
dc.titleParameters for grading the toxic severity of test chemicals : a review article in the advancement of unknown drugs into the clinicen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record